Clinical Trials Directory

Trials / Completed

CompletedNCT01030380

Determination of the Efficacy of Slendertone® Face to Tone the Muscles of the Face and Reduce the Signs of Facial Aging

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Bio-Medical Research, Ltd. · Industry
Sex
Female
Age
25 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to determine the efficacy of Slendertone® Face™, to tone the muscles of the face and reduce the signs of facial aging among the following characteristics: radiance, tone, lift, firmness and complexion, following a 12-week programme of facial muscle toning. Slendertone® Face is a neuromuscular electrical stimulation (NMES) device which features a headset unit designed for application to the face for facial toning. The purpose of the headset is to locate and support a pair of stimulation electrodes on each side of the face, over the facial nerve just anterior to the ear.

Detailed description

The trial was planned with 100 healthy female volunteers between 25 and 55 years of age. Treated group: Face device 20 minutes per day, 5 days per week for 12 weeks. Control group: No NMES. Both Groups: No changes to usual beauty routine, or use of beauty products with an anti-aging claim, or changes to usual diet or exercise habits over the course of the 12 week study period. Assessments: Ultrasound measurements of the zygomaticus major muscle were planned at Baseline, and at the end of Weeks 6 and 12. Psychometric questionnaires at Baseline, end of Weeks 6 and 12.

Conditions

Interventions

TypeNameDescription
DEVICESlendertone FaceSlendertone Face 20 minutes/day, 5 days/week for 12 weeks.

Timeline

Start date
2009-02-01
Primary completion
2009-05-01
Completion
2009-05-01
First posted
2009-12-11
Last updated
2009-12-11

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT01030380. Inclusion in this directory is not an endorsement.